Anastrozole (Arimidex) - Medication for Hormone Receptor-Positive Breast Cancer

Anastrozole, marketed under the brand name Arimidex, is a medication used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the levels of estrogen in the body.

Anastrozole (Arimidex) FAQ

Image credit: hilmabiocare.eu

What is Arimidex (anastrozole) used for?

Arimidex (anastrozole) is a prescription drug that’s used to treat breast cancer in certain situations. Arimidex comes as an oral tablet. Arimidex is prescribed to females* who’ve gone through menopause. It’s prescribed to treat certain forms of: hormone-receptor positive (HR+) early stage breast cancer, as an adjuvant (post-surgery) treatment

Is anastrozole the same as Arimidex?

Anastrozole is a hormone therapy drug used to treat breast cancer in women who have gone through a natural menopause (when periods stop). It can also be used: You may also hear it called Arimidex, which is its best-known brand name. There are a number of other brands of anastrozole, all of which contain the same dose of the drug. 2.

What is anastrozole used for?

Anastrozole is a hormonal therapy drug. It is usually only used after you have been through menopause. control breast cancer that has come back or spread to other parts of the body ( secondary breast cancer ). reduce the risk of breast cancer developing if your family history or a genetic test shows you have a higher risk of breast cancer .

Does Arimidex treat breast cancer?

Arimidex is used to treat certain forms of breast cancer in females* who’ve gone through menopause. Breast cancer causes cells in your breast to grow quickly and out of control. This fast growth can cause a tumor to form in your breast. The cancer cells may also spread to other parts of the body.

What is anastrozole (Arimidex®) used for?

Anastrozole (Arimidex®) for the adjuvant treatment of postmenopausal women with oestrogen receptor-positive early invasive breast cancer (September 2005) Anastrozole (Arimidex®) for early breast cancer in hormone receptor-positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen (November 2006)

Can anastrozole (Arimidex®) be used for early breast cancer?

Anastrozole (Arimidex®) for early breast cancer in hormone receptor-positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen (November 2006) There can be variation in the licensing of different medicines containing the same drug.